- Home
- SEED vs HIND Comparison
SEED vs HIND Comparison
Compare SEED & HIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SEED | HIND |
|---|---|---|
| Founded | 1997 | N/A |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | |
| Sector | Consumer Staples | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.6M | 12.9M |
| IPO Year | 2005 | 2016 |
Fundamental Metrics
Financial Performance| Metric | SEED | HIND |
|---|---|---|
| Price | $1.30 | $2.29 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 121.9K | 49.7K |
| Earning Date | 01-30-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.82 | $1.75 |
| 52 Week High | $2.49 | $12.87 |
Technical Indicators
Market Signals| Indicator | SEED | HIND |
|---|---|---|
| Relative Strength Index (RSI) | 51.51 | 39.64 |
| Support Level | $0.96 | $2.02 |
| Resistance Level | $1.37 | $2.93 |
| Average True Range (ATR) | 0.15 | 0.18 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 34.00 | 30.63 |
Price Performance
Historical ComparisonAbout SEED Origin Agritech Limited
Origin Agritech Ltd is a Chinese agricultural technology company operating in the PRC including seed research and development activities featured in crop seed breeding and genetic improvement. The company's phytase corn was the first transgenic corn to receive the Bio-Safety Certificate from China's Ministry of Agriculture. Origin has established a robust biotechnology seed pipeline including products with glyphosate tolerance and pest resistance (Bt) traits.
About HIND Vyome Holdings Inc.
Vyome Holdings Inc is a reseach and development company. The Company operates in two segments, biotechnology and pharmaceutical products. The biotechnology segment comprises of operations around VT-1953, VT-1908, and VB-1953 programs that are in development, and the pharmaceutical segment comprises of antifungal products manufacturing and distribution.